In the present study, the PPAR pathway inhibited the expression of PCK1, suggesting that G. elegans could be used to inhibit the excessive production of glycogen via PCK1-mediated regulation of sugar dysplasia, thus improving metabolic diseases such as type II diabetes. The gene discussed is PCK1; the disease is metabolic disease.